Clarithromycin Er Tablets 500 mg Suppliers & Bulk Manufacturers
Available Forms: Extended-Release Tablets
Available Strengths: 500 mg
Reference Brands: Biaxin (EU & US)
Category: Antibiotics
Clarithromycin ER tablets inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking translocation. They effectively treat respiratory, skin, and Helicobacter pylori infections. Benefits include rapid, broad-spectrum activity, improved tissue penetration, and convenient once-daily dosing for long-term infection management.
Product Description: Clarithromycin ER (Extended-Release) tablets are approved in the EU and US for respiratory, skin, and Helicobacter pylori infections. In the EU, brands like Biaxin XL are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on extensive clinical data, with generics available. Both regions require detailed dossiers, clinical trial results, manufacturing standards, and pharmacovigilance plans for approval and safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for clarithromycin ER tablets, ensuring adherence to European and US standards for safe, effective antibiotic therapy.
Clarithromycin Er Tablets — third party manufacturing & bulk supply
Clarithromycin Er Tablets 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Clarithromycin Er Tablets is supplied as Extended-Release Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Clarithromycin Er Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Clarithromycin Er Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Rifaximin
Strength:
100 mg/5 mL, 200 mg, 550 mg
Form: Tablet / Oral Suspension
Reference Brands: Xifaxan (USA), Targaxan (EU), Normix (LATAM)
View Details
Ceftaroline
Strength:
600 mg
Form: Injection
Reference Brands: Teflaro (USA), Zinforo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
